MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients

Journal of Neural Transmission, Supplement

Volumn , Issue 52, 1998, Pages 79-85

  Meszaros Z ^a   Borcsiczky, D ^a   Mate M ^b   Tarcali, J ^a   Tekes, K ^a   Magyar, K ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b Jahn Ferenc Del Pesti korhaz Budapest   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CLOZAPINE; HALOPERIDOL; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; ISOENZYME; SEROTONIN;

ARTICLE; CELL CULTURE; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PARANOID PSYCHOSIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SEROTONIN BRAIN LEVEL; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; BLOOD; DRUG COMBINATION; DRUG EFFECT; METABOLISM; PROBABILITY; REFERENCE VALUE; THROMBOCYTE;

ANTIPSYCHOTIC AGENTS; BLOOD PLATELETS; CLOZAPINE; DRUG THERAPY, COMBINATION; HALOPERIDOL; HUMANS; ISOENZYMES; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PROBABILITY; REFERENCE VALUES; SCHIZOPHRENIA; SEROTONIN;

EID: 0031596686     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6499-0_9     Document Type: Article

References (20)

1. Celada P, Sarrias MJ, Artigas F (1990) Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity. J Neural Transm [Suppl] 32: 149-154
2. Da Prada M, Cesura AM, Launay JM, Richards JG (1988) Platelets as a model for neurones? Experientia 44: 115-126
3. DeLisi LE, Wise CD, Bridge TP, Rosenblatt JE, Wagner RL, Morihisa J, Karson C, Potkin SG, Wyatt RJ (1981) A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients. Psychiatry Res 4: 95-107
4. Fang J, Yu PH, Gorrod JW, Boulton AA (1995) Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia. Psychopharmacology 118: 206-212
5. Freedman D, Belendiuk K, Belendiuk G, Crayton J (1981) Blood tryptophan metabolism in chronic schizophrenics. Arch Gen Psychiatry 38: 655-659
6. Garelis E, Gillin J, Wyatt R, Neff N (1975) Elevated blood serotonin concentration in unmedicated chronic schizophrenic patients. Am J Psychiatry 132: 184-186
7. Giller E, Hall H, Reubens L, Wojciechoswki J (1984) Haloperidol inhibition of monoamine oxidase in vivo and in vitro. Biol Psychiatry 19: 517-523
8. Joseph M, Owen F, Baker H, Bourne R (1977) Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenics and schizophrenic patients. Psychol Med 7: 159-162
9. Marcolin MA, Davis JM (1992) Platelet monoamine oxidase in schizophrenia: a meta-analysis. Schizophr Res 7: 249-267
10. Meltzer HY, Duncavage M, Arora RC, Tricou BJ, Jackman H, Young M (1982) Effects of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients. Am J Psychiatry 139: 1242-1247
11. Murphy DL, Donnelly CH, Miller L, Wyatt RJ (1977) Platelet monoamine oxidase in chronic schizophrenia. Arch Gen Psychiatry 33: 1377-1381
12. Mück-Seler D, Jakovljevic M, Deanovic Z (1988) Time course of schizophrenia and platelet 5-HT level. Biol Psychiatry 23: 243-251
13. Siever LJ, Kahn RS, Lawlor BA, Trestman RL, Lawrence TL, Coccaro EF (1991) Critical issues in defining the role of serotonin in psychiatric disorders. Pharm Rev 43: 509-525
14. Spivak B, Kosower N, Zipser Y, Shreiber Schul N, Apter A, Tyano S, Weizman A (1994) Platelet monoamine oxidase activity in neuroleptic-naive schizpohrenic patients: lack of influence of chronic perphenazine treatment. Clin Neuropharmacol 17(1): 83-88
15. Stahl SM (1977) The human platelets. Arch Gen Psychiatry 34: 509-516
16. Watanabe K, Kobayashi S, Oguchi K (1990) Microdetermination of human platelet MAO activity. Showa Med Lett 44(2): 205-211
17. Wirz-Justice A (1988) Platelet research in psychiatry. Experientia 44: 145-151
18. Youdim MBH (1988) Platelet monoamine oxidase B: use and misuse. Experientia 44: 137-141
19. Yu PH (1990) Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase. J Pharm Pharmacol 42: 882-884
20. Zureick JL, Meltzer HY (1988) Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysis. Biol Psychiatry 24: 63-78